» Articles » PMID: 22808248

Engineered Vascular Beds Provide Key Signals to Pancreatic Hormone-producing Cells

Overview
Journal PLoS One
Date 2012 Jul 19
PMID 22808248
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

The mechanisms underlying early islet graft failure are not entirely clear, but are thought to involve ischemic injury due to delayed vascularization. We hypothesize that blood vessels play an active role in cell-cell communications supporting islet survival and engraftment. To test this hypothesis and to uncouple endothelial cell (EC)-generated signaling stimuli from their nutritional and gas exchange functions, we developed three dimensional (3D) endothelial vessel networks in engineered pancreatic tissues prepared from islets, fibroblasts and ECs. The tri-culture setup, seeded on highly porous biocompatible polymeric scaffolds closely mimics the natural anatomical context of pancreatic vasculature. Enhanced islet survival correlating with formation of functional tube-like endothelial vessels was demonstrated. Addition of foreskin fibroblasts to islet-endothelial cultures promoted tube-like structure formation, which further supported islet survival as well as insulin secretion. Gene expression profiles of EC growth factors, extracellular matrix (ECM), morphogenes and differentiation markers were significantly different in 2D versus 3D culture systems and were further modified upon addition of fibroblasts. Implantation of prevascularized islets into diabetic mice promoted survival, integration and function of the engrafted engineered tissue, supporting the suggested role of ECs in islet survival. These findings present potential strategies for preparation of transplantable islets with increased survival prospects.

Citing Articles

Immune Evasion in Stem Cell-Based Diabetes Therapy-Current Strategies and Their Application in Clinical Trials.

Mu-U-Min R, Diane A, Allouch A, Al-Siddiqi H Biomedicines. 2025; 13(2).

PMID: 40002796 PMC: 11853723. DOI: 10.3390/biomedicines13020383.


Cell delivery systems: Toward the next generation of cell therapies for type 1 diabetes.

Dang H, Chen H, Dargaville T, Tuch B J Cell Mol Med. 2022; 26(18):4756-4767.

PMID: 35975353 PMC: 9465194. DOI: 10.1111/jcmm.17499.


A novel in vitro approach to test the effectiveness of fish oil in ameliorating type 1 diabetes.

Das M, Banerjee A, Roy R Mol Cell Biochem. 2022; 477(8):2121-2132.

PMID: 35545742 DOI: 10.1007/s11010-022-04424-1.


Development of a 3D atlas of the embryonic pancreas for topological and quantitative analysis of heterologous cell interactions.

Glorieux L, Sapala A, Willnow D, Moulis M, Salowka A, Darrigrand J Development. 2022; 149(3).

PMID: 35037942 PMC: 8918780. DOI: 10.1242/dev.199655.


In Vitro Disease Models of the Endocrine Pancreas.

Milojevic M, Rozanc J, Vajda J, Curic L, Paradiz E, Stozer A Biomedicines. 2021; 9(10).

PMID: 34680532 PMC: 8533367. DOI: 10.3390/biomedicines9101415.


References
1.
Menger M, Yamauchi J, Vollmar B . Revascularization and microcirculation of freely grafted islets of Langerhans. World J Surg. 2001; 25(4):509-15. DOI: 10.1007/s002680020345. View

2.
Lammert E, Cleaver O, Melton D . Induction of pancreatic differentiation by signals from blood vessels. Science. 2001; 294(5542):564-7. DOI: 10.1126/science.1064344. View

3.
Lesman A, Habib M, Caspi O, Gepstein A, Arbel G, Levenberg S . Transplantation of a tissue-engineered human vascularized cardiac muscle. Tissue Eng Part A. 2009; 16(1):115-25. DOI: 10.1089/ten.TEA.2009.0130. View

4.
Rigler R, Pramanik A, Jonasson P, Kratz G, Jansson O, Nygren P . Specific binding of proinsulin C-peptide to human cell membranes. Proc Natl Acad Sci U S A. 1999; 96(23):13318-23. PMC: 23945. DOI: 10.1073/pnas.96.23.13318. View

5.
Nikolova G, Jabs N, Konstantinova I, Domogatskaya A, Tryggvason K, Sorokin L . The vascular basement membrane: a niche for insulin gene expression and Beta cell proliferation. Dev Cell. 2006; 10(3):397-405. DOI: 10.1016/j.devcel.2006.01.015. View